Sensor Augmented Pump Therapy
Sensor Augmented Pump Therapy is an intervention with 7 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp
Clinical Trials (7)
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp
Full Day and Night Closed-Loop With DiAs Platform
Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
All 7 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 7